No Data
No Data
Beyond Air Receives U.S. Patent Covering Treatment of NTM Infections Using Gaseous Nitric Oxide
Beyond Air Granted U.S. Patent Covering Treatment of NTM Infections Using Gaseous Nitric Oxide (GNO)
Express News | Beyond Air Granted U.S. Patent Covering Treatment of Ntm Infections Using Gaseous Nitric Oxide (Gno)
Beyond Air Unit Receives Orphan Drug Designation for Prospective Phelan-McDermid Syndrome Treatment
12 Health Care Stocks Moving In Monday's After-Market Session
Beyond Air Shares Are Trading Higher After the Company Announced Its NeuroNOS Subsidiary Was Granted an FDA Orphan Drug Designation.
Vkandiva : this was in Feb